Evidence map›Paper›PMID 41439114›Full record

ArticleJournal of clinical and experimental hepatology

Factors Associated With Progression, Resolution and Mortality of Patients With Overt Hepatic Encephalopathy.

Maria P Ballester, Anindro Bhattacharya, Ferran Aguilar, François Fenaille, Cristina Sánchez-Garrido, Richard Moreau, Vicente Arroyo, Victor Vargas, Wim Laleman, Joan Clària and 5 more

Abstract read
In one paragraph

Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maria P BallesterDigestive Disease Department, Hospital Clínico Universitario de Valencia, Spain.
Anindro BhattacharyaUniversity of Pennsylvania, Department of Bioengineering, Philadelphia, United States.
Ferran AguilarEuropean Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain.
François FenailleUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, MetaboHUB, Gif-sur-Yvette, France.
Cristina Sánchez-GarridoEuropean Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain.
Richard MoreauEuropean Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain.
Vicente ArroyoEuropean Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain.
Victor VargasFacultad de Medicina, Unidad docente Vall d'Hebron, Universidad Autónoma de Barcelona, Spain.
Wim LalemanDepartment of Gastroenterology & Hepatology, Division of Liver & Biliopancreatic disorders and Liver Transplantation, University Hospitals Leuven, KU LEUVEN, Leuven, Belgium.
Joan ClàriaEuropean Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain.
Jonel TrebickaEuropean Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain.
Juan A Carbonel-AsinsINCLIVA Biomedical Research Institute, Valencia, Spain.
Christopher F RoseHepato-Neuro Laboratory, CRCHUM, Université de Montréal, Montreal, Canada.
Rajiv JalanInstitute for Liver and Disease Health, University College London, London, United Kingdom.
Predict Study Group and AMMON Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Overt hepatic encephalopathy (OHE) is a reversible complication of cirrhosis that often results in hospitalization. Factors associated with progression, resolution and mortality are not known, particularly with confounders such as acute-on-chronic liver failure (ACLF). The aim of the study was to evaluate factors associated with progression, resolution, and mortality of patients with OHE. Methods: Data for this study were derived from PREDICT, a prospective cohort study of patients with cirrhosis hospitalized for an acute decompensation or ACLF. Progression to OHE or worsening in severity and resolution from OHE were evaluated at 1 week. Cox regression, interaction analyses, and Kaplan-Meier curves were performed. Results: One thousand two hundred seventy-three patients were included [68% males; 59 (51-67) years; 56% alcohol], 16% admitted with OHE and 16% with ACLF. Older age, metabolic dysfunction-associated steatotic liver disease, previous treatment with lactulose, ACLF, white blood cell counts or albumin levels at admission were associated with OHE ( Conclusion: Presence of ACLF and progression of OHE are associated with high short-term mortality rates, while resolution of OHE is associated with significantly better prognosis. Understanding the natural history of OHE will have profound implications on the development of novel approaches.

Indexed as

acute-on-chronic liver failurecirrhosisnatural historyovert hepatic encephalopathyprognosis

Identifiers

PMID41439114
PMCPMC12720073

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.